Loperamide

General Information

Loperamide Impurities and Loperamide

For evaluating the purity and safety of Loperamide, an active pharmaceutical ingredient, Daicel Pharma offers a customized synthesis of Loperamide impurity standards. These impurity standards include crucial compounds such as Desmethyl Loperamide and Didesmethyl Loperamide. Additionally, Daicel Pharma provides worldwide delivery options for Loperamide impurity standards.

Loperamide [CAS: 53179-11-6] is a long-acting synthetic antidiarrheal agent. It primarily acts on opiate receptors in the intestine to effectively treat diarrhea. Loperamide is not substantially absorbed from the gut and does not affect the central nervous system.

Loperamide: Use and Commercial Availability

Imodium and Imodium A-D are the brand names for the drug Loperamide, an over-the-counter oral antidiarrheal agent. Initially categorized as a Schedule V drug by the FDA due to its potential for opioid-like abuse, it is now FDA-approved for treating various forms of diarrhea. It is also commonly used off-label to manage chemotherapy-induced diarrhea. In recent years, there has been increased non-medical use of Loperamide for purposes such as self-management of opioid withdrawal symptoms and recreational use. It relieves diarrhea, including Travelers’ Diarrhea, and alleviates chemotherapy-related diarrhea.

Loperamide Structure and Mechanism of Action 

The chemical name of Loperamide is 4-(4-Chlorophenyl)-4-hydroxy-N, N-dimethyl-α, α-diphenyl-1-piperidinebutanamide. Its chemical formula is C₂₉H₃₃ClN₂O₂, and its molecular weight is approximately 477.0 g/mol.

Loperamide slows intestinal motility by inhibiting the release of acetylcholine and prostaglandins.

Loperamide Impurities and Synthesis

Impurities in Loperamide refer to unintended substances present in the drug formulation, distinct from the desired active pharmaceutical ingredient (API). They can originate from various sources, including manufacturing, starting materials, or interactions with other compounds. Common Loperamide impurities include related compounds, degradation products, residual solvents, and process-related impurities. Strict monitoring and control of impurity levels during manufacturing ensure the safety, efficacy, and quality of Loperamide. Regulatory guidelines and limits govern the acceptable levels of impurities in the final drug product, aiming to minimize potential adverse effects and maintain product purity.

Daicel Pharma strictly adheres to cGMP standards and operates an analytical facility for preparing Loperamide impurity standards, which include Desmethyl Loperamide and Didesmethyl Loperamide. Our Loperamide impurity standards have a detailed Certificate of Analysis (CoA) that provides a comprehensive characterization report. This report has data obtained through techniques, 1H NMR, 13C NMR, IR, MASS, and HPLC purity analysis^{1, 2}. Upon request, we give additional data like 13C-DEPT. Moreover, we can synthesize unknown Loperamide impurity standards and degradation products. Each delivery has a comprehensive characterization report.